Search - tctmd.com

Displaying 181 - 200 of 2597

Sort: Relevancy | Date

News Conference News TCT 2024

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Caitlin E. Cox

November 04, 2024

News Conference News TCT 2024

PAD Patients’ Views on Decisions and Outcomes Hinge on Sex, Race/Ethnicity: ELEGANCE

L.A. McKeown

November 04, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Todd Neale

October 31, 2024

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

Presenter: Tomas Kovarnik

October 30, 2024

Presentation TCT 2024

TCT 999: ReliaSeal Trial: A Randomized Trial of Multiple Venous Access Closure With MYNX CONTROL™ VENOUS Vascular Closure Device and Manual Compression After Catheter-Based Ablation Procedures

Presenter: Sanjaya Gupta

October 30, 2024

Presentation TCT 2024

Left Atrial Appendage Closure with a Novel Fluoropolymer-Coated Device: The HEAL-LAA Post-Approval Clinical Study

Presenter: Seun Alli

October 30, 2024

Presentation TCT 2024

One-Year Follow-Up of the US Early Feasibility Study Evaluating Rotational Closure of the LAA Using the Laminar Device

Presenter: Saibal Kar

October 30, 2024

Presentation TCT 2024

Lesion Preparation Innovations in IVL– Will Next Generation Devices Move the Needle?

Presenter: William Gray

October 30, 2024

Presentation TCT 2024

TCT 550: Cardiovascular Outcomes and Comparison of Low vs Intermediate High Hospital Frailty Index on Watchman Device and Associated Readmissions: A Nationwide Readmission Database Analysis

Presenter: Krutarth Pandya

October 30, 2024

Presentation TCT 2024

TCT 549: Association of Left Atrial Appendage Anatomy With Peri-Device Leak at Mid-Term Follow Up

Presenter: Lu Chen

October 30, 2024

Presentation TCT 2024

FDA Perspectives and Regulatory Pathways for AI-Enabled Cardiovascular Devices

Presenter: Stephen Browning

October 30, 2024

Presentation TCT 2024

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Presenter: Jerry Lipinski

October 30, 2024

Presentation TCT 2024

TCT 585: Impella CP and 5.5 Device Flows Are Overestimated by the SmartAssist Automated Impella Controller (AIC)

Presenter: Christian Said

October 30, 2024

Presentation TCT 2024

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

Presenter: Neethi Dasu

October 30, 2024

Advertisement

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

PAD Patients’ Views on Decisions and Outcomes Hinge on Sex, Race/Ethnicity: ELEGANCE

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

TCT 999: ReliaSeal Trial: A Randomized Trial of Multiple Venous Access Closure With MYNX CONTROL™ VENOUS Vascular Closure Device and Manual Compression After Catheter-Based Ablation Procedures

Left Atrial Appendage Closure with a Novel Fluoropolymer-Coated Device: The HEAL-LAA Post-Approval Clinical Study

One-Year Follow-Up of the US Early Feasibility Study Evaluating Rotational Closure of the LAA Using the Laminar Device

Lesion Preparation Innovations in IVL– Will Next Generation Devices Move the Needle?

TCT 550: Cardiovascular Outcomes and Comparison of Low vs Intermediate High Hospital Frailty Index on Watchman Device and Associated Readmissions: A Nationwide Readmission Database Analysis

TCT 549: Association of Left Atrial Appendage Anatomy With Peri-Device Leak at Mid-Term Follow Up

FDA Perspectives and Regulatory Pathways for AI-Enabled Cardiovascular Devices

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

TCT 585: Impella CP and 5.5 Device Flows Are Overestimated by the SmartAssist Automated Impella Controller (AIC)

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content